首页 | 本学科首页   官方微博 | 高级检索  
检索        

甲强龙联合地塞米松交替球周注射治疗脉络膜脱离型视网膜脱离
引用本文:韩林峰,柯根杰,顾永昊,董凯.甲强龙联合地塞米松交替球周注射治疗脉络膜脱离型视网膜脱离[J].眼科新进展,2015,0(10):935-938.
作者姓名:韩林峰  柯根杰  顾永昊  董凯
作者单位:230001 安徽省合肥市,安徽医科大学附属省立医院眼科
摘    要:目的 评价甲强龙联合地塞米松交替球周注射在玻璃体切割术治疗脉络膜脱离型视网膜脱离中的疗效。方法 回顾性分析我科2012年1月至2013年12月收治的临床确诊为脉络膜脱离型视网膜脱离的患者共46例46眼。按糖皮质激素的给药途径,分为静脉组与球周组各23例23眼,均行玻璃体切除+硅油充填术,术后随访12个月以上。对比两组手术前后最佳矫正视力、眼压、术前糖皮质激素使用时间、不良反应发生率、视网膜脱离一次手术复位率、视网膜脱离复发率等。结果 静脉组与球周组患者入院时眼压分别为(6.74±2.33)mmHg(1kPa=7.5mmHg)和(6.96±1.88)mmHg,使用糖皮质激素后术前眼压分别为(9.34±1.50)mmHg和(9.43±1.08)mmHg;最佳矫正视力入院时分别为2.07±0.14和2.23±0.16,出院时分别为2.02±0.17和2.03±0.14,两组组内比较差异均有统计学意义(均为P<0.05),而组间比较差异均无统计学意义(均为P>0.05)。术后12个月内静脉组与球周组一次性视网膜脱离复位例数分别为19例和21例、视网膜脱离复发例数分别为4例和2例,差异均无统计学意义(均为P>0.05);而两组在术前糖皮质激素使用时间,静脉组为(5.35±0.12)d、球周组为(4.04±0.38)d,差异有统计学意义(t=2.31,P=0.03);糖皮质激素使用不良反应,静脉组为6例、球周组为0例,差异有统计学意义(χ2=6.9,P=0.009)。结论 甲强龙联合地塞米松交替球周注射是一种玻璃体切割术治疗脉络膜脱离型视网膜脱离的安全有效的方法。

关 键 词:糖皮质激素  球周注射  脉络膜脱离型视网膜脱离  眼压  最佳矫正视力

Alternating peribulbar injection of methylprednisolone and dexamethasone for combined choroidal detachment and retinal detachment
HAN Lin-Feng,KE Gen-Jie,GU Yong-Hao,DONG Kai.Alternating peribulbar injection of methylprednisolone and dexamethasone for combined choroidal detachment and retinal detachment[J].Recent Advances in Ophthalmology,2015,0(10):935-938.
Authors:HAN Lin-Feng  KE Gen-Jie  GU Yong-Hao  DONG Kai
Institution:Department of Ophthalmology , Anhui Provincial Hospital , Anhui Medical University , Hefei 230001 , Anhui Province . China
Abstract:Objective To evaluate curative effects of alternating peribulbar injection of methylprednisolone and dexamethasone in vitrectomy for choriodal detachment and retinal detachment. Methods Retrospective analysis was performed on 46 cases (46 eyes) of patients who were definitely diagnosed as choriodal detachment and retinal detachment . and accepted treatment in our department from January 2012 to December 2013. The patients were divided into two groups , namely vein group and peribulbar group according to administration route of glucocorticoid.23 cases in each group. The vitrectomy and silicone oil filling operation was applied for both groups and follow-up treatment was performed for more than six months. The preoperative and postoperative best corrected visual acuity , intraocular pressure variation, preoperative glucocorticoid applying time.occurrence rate of adverse reaction.one-time surgical reduction rate of retinal detachment, recurrence of retinal detachment were analyzed in the two groups. Results The intraocular pressure in vein group and peribulbar group at being admitted to hospital were ( 6. 74 +2. 33) mmHg ( I kPa = 7. 5 mmHg) and ( 6. 96 + 1. 88 ) mmHg , respectively, the preoperative intraocular pressure after applying glucocorticoid were ( 9. 34 + 1. 50) mmHg and ( 9. 43 + 1. 08 ) mmHg , respectively ; The best corrected visual acuity at being admitted to hospital were 2. 07 + 0. 14 and 2. 23 + 0. 16 , respectively , and were 2. 02 + 0. 17 and l. 03 + 0. 14 when discharged from the hospital, there were statistical differences between intra-groups(P < 0. 05 ) ,while the difference among groups was not statistically sigruficant(P > 0. 05 ) . The one-time retinal detachment reduction cases of vein group and peribulbar group within 12 months were 19 and 21 , respectively. The reduction cases of retinal detachment were 4 and 2 , respectively. The difference was not statistically significant(P > 0. 05 ) . The applying time of preoperative glucocorticoid in the vein group and peribulbar group were ( 5. 35 + 0. 12 ) days and ( 4. 04 + 0. 38 ) days ( t = 2. 31 ,P = 0. 03 ) . The adverse reaction of glucocorticoid application in the vein group and peribulbar group were 6 cases and o case(X2 = 6. 9 ,P = 0. 009) . Conclusion Alternating peribulbar injection of methylprednisolone and dexamethasone is a safe and effective therapy method in vitrectomy for choriodal detachment and retinal detachment.
Keywords:glucocorticoid  peribulbar injection  choroidal detachment and retinal detachment  intraocular pressure  best corrected visual acuity
点击此处可从《眼科新进展》浏览原始摘要信息
点击此处可从《眼科新进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号